Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trialFeng Wang, Rui‐Hua Xu, Weijia Fang et al.|Nature Medicine|2024Cited by 162